Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
AstraZeneca
Baxter
Moodys
Johnson and Johnson

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DEXMETHYLPHENIDATE HYDROCHLORIDE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Dexmethylphenidate Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00047476 D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients Completed Celgene Corporation Phase 2 2002-06-01 To evaluate the efficacy of dexmethylphenidate (d-MPH) in the treatment of chemotherapy-related fatigue in adult cancer subjects.
NCT00141050 Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD Completed Novartis Phase 3 2005-05-01 The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD.
NCT00141063 Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD Completed Novartis Phase 3 2005-06-01 The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD.
NCT00301236 Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder Completed Novartis Phase 3 2006-02-01 The purpose of this study is to determine which dosages of dexmethylphenidate HCl extended-release capsules may represent effective treatment for ADHD in children 6-12 years of age.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Dexmethylphenidate Hydrochloride

Condition Name

Condition Name for Dexmethylphenidate Hydrochloride
Intervention Trials
Sarcoidosis 2
Healthy 2
ADHD 2
Fatigue 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Dexmethylphenidate Hydrochloride
Intervention Trials
Attention Deficit Disorder with Hyperactivity 3
Fatigue 3
Sarcoidosis 2
Hyperkinesis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Dexmethylphenidate Hydrochloride

Trials by Country

Trials by Country for Dexmethylphenidate Hydrochloride
Location Trials
United States 36
Brazil 1
United Kingdom 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Dexmethylphenidate Hydrochloride
Location Trials
Massachusetts 2
California 2
Illinois 2
Ohio 2
Missouri 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Dexmethylphenidate Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Dexmethylphenidate Hydrochloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 4
Phase 2 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Dexmethylphenidate Hydrochloride
Clinical Trial Phase Trials
Completed 9
Not yet recruiting 1
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Dexmethylphenidate Hydrochloride

Sponsor Name

Sponsor Name for Dexmethylphenidate Hydrochloride
Sponsor Trials
Novartis 4
Teva Pharmaceuticals USA 2
University of Illinois at Chicago 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Dexmethylphenidate Hydrochloride
Sponsor Trials
Other 7
Industry 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
McKesson
Medtronic
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.